Highlighting the Potential Role of Exosomes as the Targeted Nanotherapeutic Carrier in Metastatic Breast Cancer

被引:5
|
作者
Khera, Alisha [1 ,2 ]
Alajangi, Hema K. [1 ,3 ]
Khajuria, Akhil [3 ]
Barnwal, Ravi P. [1 ]
Kumar, Santosh [2 ]
Singh, Gurpal [3 ]
机构
[1] Panjab Univ, Dept Biophys, Chandigarh 160014, India
[2] SP Pune Univ Campus, Natl Ctr Cell Sci, NCCS Complex, Pune 411007, Maharashtra, India
[3] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
关键词
Breast cancer; exosomes; nanovehicles; engineering strategies; tumor; treatment; MACROPHAGE-DERIVED EXOSOMES; EXTRACELLULAR VESICLES; IN-VITRO; DRUG-DELIVERY; MEDIATED DELIVERY; ENGINEERING EXOSOMES; SYNERGISTIC THERAPY; CELLS; DISPLAY; BIOGENESIS;
D O I
10.2174/1567201819666220404103936
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breast cancer, being the second most common type of cancer, is a leading cause of death in the female population. Of all the available treatments existing for breast cancer, exosomes appear as an important medium for the site targeted delivery of the drugs. Exosomes, unlike all the other extracellular vesicles, play a vital role in the transport of numerous biomolecules throughout the body and can easily be detected because of the presence of specific biomarkers. Apart from playing a wide variety of roles in the progression of many diseases, they are also responsible for tumor progression and metastasis in breast cancer. Exosomes and related engineering strategies are being discussed as nano-carrier for the delivery of different drugs in the case of breast cancer. Overall, we have discussed in this review the role of exosomes in breast cancer and the engineering strategies being devised for making them an efficient drug delivery system.
引用
收藏
页码:317 / 334
页数:18
相关论文
共 50 条
  • [1] Cancer stem cell targeted exosomes for the treatment of metastatic breast cancer
    Kibria, Golam
    Lee, Katelyn E.
    Ramos, Erika K.
    Huang, Simo
    Harding, Clifford V.
    Lotvall, Jan
    Liu, Huiping
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Recent advances in targeted nanotherapeutic approaches for breast cancer management
    Gupta, Priya
    Neupane, Yub Raj
    Parvez, Suhel
    Kohli, Kanchan
    [J]. NANOMEDICINE, 2021, 16 (29) : 2605 - 2631
  • [3] The Role of Targeted Agents in the Treatment of Metastatic Breast Cancer
    Bischoff, Joachim
    Ignatov, Atanas
    [J]. BREAST CARE, 2010, 5 (03) : 134 - 141
  • [4] The role of chemotherapy and targeted agents in patients with metastatic breast cancer
    Johnston, Stephen R. D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S38 - S47
  • [5] The Role of Exosomes in Breast Cancer
    Lowry, Michelle C.
    Gallagher, William M.
    O'Driscoll, Lorraine
    [J]. CLINICAL CHEMISTRY, 2015, 61 (12) : 1457 - 1465
  • [6] Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential
    Gangoda, Lahiru
    Liem, Michael
    Ang, Ching-Seng
    Keerthikumar, Shivakumar
    Adda, Christopher G.
    Parker, Belinda S.
    Mathivanan, Suresh
    [J]. PROTEOMICS, 2017, 17 (23-24)
  • [7] Spatiotemporal progression of metastatic breast cancer: A markov chain model highlighting the role of early metastatic sites
    Newton P.K.
    Mason J.
    Venkatappa N.
    Jochelson M.S.
    Hurt B.
    Nieva J.
    Comen E.
    Norton L.
    Kuhn P.
    [J]. npj Breast Cancer, 1 (1)
  • [8] Comparison of exosomes shed by breast cancer cell lines with varying metastatic potential
    Martin, Kelly A.
    Hum, Nicholas R.
    Sebastian, Aimy
    Loots, Gabriela G.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [9] Targeted therapy of metastatic breast cancer
    Alfonso Sánchez-Muñoz
    Elisabeth Pérez-Ruiz
    Begoña Jiménez
    Nuria Ribelles
    Antonia Márquez
    Isabel García-Ríos
    Emilio Alba Conejo
    [J]. Clinical and Translational Oncology, 2009, 11 : 643 - 650
  • [10] Targeted therapy of metastatic breast cancer
    Sanchez-Munoz, Alfonso
    Perez-Ruiz, Elisabeth
    Jimenez, Begona
    Ribelles, Nuria
    Marquez, Antonia
    Garcia-Rios, Isabel
    Alba Conejo, Emilio
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (10): : 643 - 650